Literature DB >> 16150144

Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.

G R Sridhar1, G Nirmala, Allam Apparao, A S Madhavi, S Sreelatha, J Sudha Rani, P Vijayalakshmi.   

Abstract

BACKGROUND: Butyrylcholinesterase is an enzyme that may serve as a marker of metabolic syndrome. We (a) measured its level in persons with diabetes mellitus, (b) constructed a family tree of the enzyme using nucleotide sequences downloaded from NCBI. Butyrylcholinesterase was estimated colorimetrically using a commercially available kit (Randox Lab, UK). Phylogenetic trees were constructed by distance method (Fitch and Margoliash method) and by maximum parsimony method.
RESULTS: There was a negative correlation between serum total cholesterol and butyrylcholinesterase (-0.407; p < 0.05) and between serum LDL cholesterol and butyrylcholinesterase (-0.435; p < 0.05). There was no statistically significant correlation among the other biochemical parameters. In the evolutionary tree construction both methods gave similar trees, except for an inversion in the position of Sus scrofa (M62778) and Oryctolagus cuniculus (M62779) between Fitch and Margoliash, and maximum parsimony methods.
CONCLUSION: The level of butyrylcholinesterase enzyme was inversely related to serum cholesterol; dendrogram showed that the structures from evolutionarily close species were placed near each other.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150144      PMCID: PMC1242349          DOI: 10.1186/1476-511X-4-18

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  11 in total

1.  Serum gamma-glutamyltransferase and/or serum cholinesterase as markers of the metabolic syndrome.

Authors:  M Cucuianu
Journal:  Diabetes Care       Date:  1999-08       Impact factor: 19.112

2.  Molecular and morphological supertrees for eutherian (placental) mammals.

Authors:  F G Liu; M M Miyamoto; N P Freire; P Q Ong; M R Tennant; T S Young; K F Gugel
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

3.  Butyrylcholinesterase activity and metabolic syndrome in obese patients.

Authors:  Vânia M Alcântara; Lisangela C Oliveira; Rosângela R Réa; Henrique L Suplicy; Eleidi A Chautard-Freire-Maia
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

4.  Hormone-sensitive lipase is structurally related to acetylcholinesterase, bile salt-stimulated lipase, and several fungal lipases. Building of a three-dimensional model for the catalytic domain of hormone-sensitive lipase.

Authors:  J A Contreras; M Karlsson; T Osterlund; H Laurell; A Svensson; C Holm
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

5.  Effects of oxprenolol treatment on pseudocholinesterase and lipids in rats.

Authors:  Z Krnić; V Bradamante
Journal:  Arzneimittelforschung       Date:  1997-08

Review 6.  Impact of human genome project on medical practice.

Authors:  G R Sridhar
Journal:  J Assoc Physicians India       Date:  2001-10

7.  Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?

Authors:  C Rustemeijer; J A Schouten; H J Voerman; A C Beynen; A J Donker; R J Heine
Journal:  Clin Sci (Lond)       Date:  2001-07       Impact factor: 6.124

8.  Butyrylcholinesterase activity and risk factors for coronary artery disease.

Authors:  V M Alcântara; E A Chautard-Freire-Maia; M Scartezini; M S J Cerci; K Braun-Prado; G Picheth
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

9.  Relationship between serum butyrylcholinesterase and the metabolic syndrome.

Authors:  Edward W Randell; Maria S Mathews; Hongwei Zhang; Jim S Seraj; Guang Sun
Journal:  Clin Biochem       Date:  2005-09       Impact factor: 3.281

10.  Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.

Authors:  K M Kutty; S N Huang; K T Kean
Journal:  Experientia       Date:  1981-11-15
View more
  9 in total

Review 1.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

Review 2.  Emerging links between type 2 diabetes and Alzheimer's disease.

Authors:  Gumpeny R Sridhar; Gumpeny Lakshmi; Gumpeny Nagamani
Journal:  World J Diabetes       Date:  2015-06-10

3.  Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index.

Authors:  Karine S De Bona; Gabriela Bonfanti; Paula E R Bitencourt; Lariane O Cargnelutti; Priscila S da Silva; Leidiane De Lucca; Victor C Pimentel; Etiane Tatsch; Thissiane L Gonçalves; Melissa Premaor; Rafael N Moresco; Maria Beatriz Moretto
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

4.  The relation of high fat diet, metabolic disturbances and brain oxidative dysfunction: modulation by hydroxy citric acid.

Authors:  Kamal A Amin; Hamdy H Kamel; Mohamed A Abd Eltawab
Journal:  Lipids Health Dis       Date:  2011-05-14       Impact factor: 3.876

5.  Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?

Authors:  Gumpeny Ramachandra Sridhar; Hanuman Thota; Appa Rao Allam; Changalasetty Suresh Babu; Akula Siva Prasad; Ch Divakar
Journal:  Lipids Health Dis       Date:  2006-11-11       Impact factor: 3.876

6.  Molecular dynamic simulations of Escherichia coli L-asparaginase to illuminate its role in deamination of asparagine and glutamine residues.

Authors:  Rajeswara Reddy Erva; Satish Babu Rajulapati; Chandrasai Potla Durthi; Mayuri Bhatia; Madhuri Pola
Journal:  3 Biotech       Date:  2015-12-29       Impact factor: 2.406

Review 7.  Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Aleksandra Szydłowska; Agata Skupień; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

8.  Plasma proteomics reveals markers of metabolic stress in HIV infected children with severe acute malnutrition.

Authors:  Gerard Bryan Gonzales; James M Njunge; Bonface M Gichuki; Bijun Wen; Isabel Potani; Wieger Voskuijl; Robert H J Bandsma; James A Berkley
Journal:  Sci Rep       Date:  2020-07-08       Impact factor: 4.379

Review 9.  Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease.

Authors:  Lucie Cahlíková; Rudolf Vrabec; Filip Pidaný; Rozálie Peřinová; Negar Maafi; Abdullah Al Mamun; Aneta Ritomská; Viriyanata Wijaya; Gerald Blunden
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.